Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet

Naoki Tanaka, Shogo Takahashi, Yuan Zhang, Kristopher W. Krausz, Philip B. Smith, Andrew D. Patterson, Frank J. Gonzalez

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Fibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in human nonalcoholic liver disease (NAFLD) and after feeding of methionine- and choline-deficient diet (MCD), a conventional inducer of murine nonalcoholic steatohepatitis (NASH). However, the significance of FGF21 induction in the occurrence of MCD-induced NASH remains undetermined. C57BL/6J Fgf21-null and wild-type mice were treated with MCD for 1. week. Hepatic Fgf21 mRNA was increased early after commencing MCD treatment independent of peroxisome proliferator-activated receptor (PPAR) α and farnesoid X receptor. While no significant differences in white adipose lipolysis were seen in both genotypes, hepatic triglyceride (TG) contents were increased in Fgf21-null mice, likely due to the up-regulation of genes encoding CD36 and phosphatidic acid phosphatase 2a/2c, involved in fatty acid (FA) uptake and diacylglycerol synthesis, respectively, and suppression of increased mRNAs encoding carnitine palmitoyl-CoA transferase 1α, PPARγ coactivator 1α, and adipose TG lipase, which are associated with lipid clearance in the liver. The MCD-treated Fgf21-null mice showed increased hepatic endoplasmic reticulum (ER) stress. Exposure of primary hepatocytes to palmitic acid elevated the mRNA levels encoding DNA damage-inducible transcript 3, an indicator of ER stress, and FGF21 in a PPARα-independent manner, suggesting that lipid-induced ER stress can enhance hepatic FGF21 expression. Collectively, FGF21 is elevated in the early stage of MCD-induced NASH likely to minimize hepatic lipid accumulation and ensuing ER stress. These results provide a possible mechanism on how FGF21 is increased in NAFLD/NASH.

Original languageEnglish (US)
Pages (from-to)1242-1252
Number of pages11
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1852
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Choline
Methionine
Endoplasmic Reticulum Stress
Diet
Peroxisome Proliferator-Activated Receptors
Liver
Lipids
Messenger RNA
Coenzyme A-Transferases
Phosphatidate Phosphatase
Palmitoyl Coenzyme A
Palmitic Acid
Carnitine
Lipolysis
Diglycerides
Lipase
DNA Damage
Non-alcoholic Fatty Liver Disease
fibroblast growth factor 21
Liver Diseases

Keywords

  • ATGL
  • ER stress
  • Lipotoxicity
  • PGC1α
  • PPARα

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. / Tanaka, Naoki; Takahashi, Shogo; Zhang, Yuan; Krausz, Kristopher W.; Smith, Philip B.; Patterson, Andrew D.; Gonzalez, Frank J.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, No. 7, 01.07.2015, p. 1242-1252.

Research output: Contribution to journalArticle

Tanaka, Naoki ; Takahashi, Shogo ; Zhang, Yuan ; Krausz, Kristopher W. ; Smith, Philip B. ; Patterson, Andrew D. ; Gonzalez, Frank J. / Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2015 ; Vol. 1852, No. 7. pp. 1242-1252.
@article{1d3bd01666674b1a8c64f697b19f9483,
title = "Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet",
abstract = "Fibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in human nonalcoholic liver disease (NAFLD) and after feeding of methionine- and choline-deficient diet (MCD), a conventional inducer of murine nonalcoholic steatohepatitis (NASH). However, the significance of FGF21 induction in the occurrence of MCD-induced NASH remains undetermined. C57BL/6J Fgf21-null and wild-type mice were treated with MCD for 1. week. Hepatic Fgf21 mRNA was increased early after commencing MCD treatment independent of peroxisome proliferator-activated receptor (PPAR) α and farnesoid X receptor. While no significant differences in white adipose lipolysis were seen in both genotypes, hepatic triglyceride (TG) contents were increased in Fgf21-null mice, likely due to the up-regulation of genes encoding CD36 and phosphatidic acid phosphatase 2a/2c, involved in fatty acid (FA) uptake and diacylglycerol synthesis, respectively, and suppression of increased mRNAs encoding carnitine palmitoyl-CoA transferase 1α, PPARγ coactivator 1α, and adipose TG lipase, which are associated with lipid clearance in the liver. The MCD-treated Fgf21-null mice showed increased hepatic endoplasmic reticulum (ER) stress. Exposure of primary hepatocytes to palmitic acid elevated the mRNA levels encoding DNA damage-inducible transcript 3, an indicator of ER stress, and FGF21 in a PPARα-independent manner, suggesting that lipid-induced ER stress can enhance hepatic FGF21 expression. Collectively, FGF21 is elevated in the early stage of MCD-induced NASH likely to minimize hepatic lipid accumulation and ensuing ER stress. These results provide a possible mechanism on how FGF21 is increased in NAFLD/NASH.",
keywords = "ATGL, ER stress, Lipotoxicity, PGC1α, PPARα",
author = "Naoki Tanaka and Shogo Takahashi and Yuan Zhang and Krausz, {Kristopher W.} and Smith, {Philip B.} and Patterson, {Andrew D.} and Gonzalez, {Frank J.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.bbadis.2015.02.012",
language = "English (US)",
volume = "1852",
pages = "1242--1252",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet

AU - Tanaka, Naoki

AU - Takahashi, Shogo

AU - Zhang, Yuan

AU - Krausz, Kristopher W.

AU - Smith, Philip B.

AU - Patterson, Andrew D.

AU - Gonzalez, Frank J.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Fibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in human nonalcoholic liver disease (NAFLD) and after feeding of methionine- and choline-deficient diet (MCD), a conventional inducer of murine nonalcoholic steatohepatitis (NASH). However, the significance of FGF21 induction in the occurrence of MCD-induced NASH remains undetermined. C57BL/6J Fgf21-null and wild-type mice were treated with MCD for 1. week. Hepatic Fgf21 mRNA was increased early after commencing MCD treatment independent of peroxisome proliferator-activated receptor (PPAR) α and farnesoid X receptor. While no significant differences in white adipose lipolysis were seen in both genotypes, hepatic triglyceride (TG) contents were increased in Fgf21-null mice, likely due to the up-regulation of genes encoding CD36 and phosphatidic acid phosphatase 2a/2c, involved in fatty acid (FA) uptake and diacylglycerol synthesis, respectively, and suppression of increased mRNAs encoding carnitine palmitoyl-CoA transferase 1α, PPARγ coactivator 1α, and adipose TG lipase, which are associated with lipid clearance in the liver. The MCD-treated Fgf21-null mice showed increased hepatic endoplasmic reticulum (ER) stress. Exposure of primary hepatocytes to palmitic acid elevated the mRNA levels encoding DNA damage-inducible transcript 3, an indicator of ER stress, and FGF21 in a PPARα-independent manner, suggesting that lipid-induced ER stress can enhance hepatic FGF21 expression. Collectively, FGF21 is elevated in the early stage of MCD-induced NASH likely to minimize hepatic lipid accumulation and ensuing ER stress. These results provide a possible mechanism on how FGF21 is increased in NAFLD/NASH.

AB - Fibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in human nonalcoholic liver disease (NAFLD) and after feeding of methionine- and choline-deficient diet (MCD), a conventional inducer of murine nonalcoholic steatohepatitis (NASH). However, the significance of FGF21 induction in the occurrence of MCD-induced NASH remains undetermined. C57BL/6J Fgf21-null and wild-type mice were treated with MCD for 1. week. Hepatic Fgf21 mRNA was increased early after commencing MCD treatment independent of peroxisome proliferator-activated receptor (PPAR) α and farnesoid X receptor. While no significant differences in white adipose lipolysis were seen in both genotypes, hepatic triglyceride (TG) contents were increased in Fgf21-null mice, likely due to the up-regulation of genes encoding CD36 and phosphatidic acid phosphatase 2a/2c, involved in fatty acid (FA) uptake and diacylglycerol synthesis, respectively, and suppression of increased mRNAs encoding carnitine palmitoyl-CoA transferase 1α, PPARγ coactivator 1α, and adipose TG lipase, which are associated with lipid clearance in the liver. The MCD-treated Fgf21-null mice showed increased hepatic endoplasmic reticulum (ER) stress. Exposure of primary hepatocytes to palmitic acid elevated the mRNA levels encoding DNA damage-inducible transcript 3, an indicator of ER stress, and FGF21 in a PPARα-independent manner, suggesting that lipid-induced ER stress can enhance hepatic FGF21 expression. Collectively, FGF21 is elevated in the early stage of MCD-induced NASH likely to minimize hepatic lipid accumulation and ensuing ER stress. These results provide a possible mechanism on how FGF21 is increased in NAFLD/NASH.

KW - ATGL

KW - ER stress

KW - Lipotoxicity

KW - PGC1α

KW - PPARα

UR - http://www.scopus.com/inward/record.url?scp=84925778793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925778793&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2015.02.012

DO - 10.1016/j.bbadis.2015.02.012

M3 - Article

VL - 1852

SP - 1242

EP - 1252

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 7

ER -